Carl Zeiss Meditec AG (ETR:AFX)

Carl Zeiss Meditec AG Balance Sheet

Financials in millions EUR. Fiscal year is October - September.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	-	27.27	20.29	10.6	7.73	7.44
Cash & Short-Term Investments	23.9	27.27	20.29	10.6	7.73	7.44
Cash Growth	-	34.42%	91.35%	37.16%	3.90%	19.95%
Accounts Receivable	-	520.82	438.12	421.45	414.28	323.51
Other Receivables	-	170.86	144.82	875.7	912.18	970.18
Receivables	-	691.68	582.94	1,297	1,326	1,294
Inventory	-	497.21	536.56	520.23	382.75	286.38
Prepaid Expenses	-	-	-	-	-	8.56
Other Current Assets	-	64.14	72.71	83.75	74.92	7.95
Total Current Assets	-	1,280	1,212	1,912	1,792	1,604
Property, Plant & Equipment	-	285.84	263.89	250.66	201.3	177.39
Long-Term Investments	-	28.93	20.38	21.46	10.83	6.71
Goodwill	-	969.74	982.51	415.78	429.65	328.71
Other Intangible Assets	-	279.93	304.48	13.31	15.6	16.58
Long-Term Accounts Receivable	-	9.39	8.56	7.02	8.47	9.19
Long-Term Deferred Tax Assets	-	82.26	86.32	63.7	71.75	84.96
Long-Term Deferred Charges	-	382.95	402.38	246.18	224.83	137.12
Other Long-Term Assets	-	73.87	105.55	96.97	68.39	31.28
Total Assets	-	3,403	3,393	3,033	2,823	2,396

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Accounts Payable	-	194.1	183.54	239.79	189.19	145.47
Accrued Expenses	-	132.17	123.64	106.52	95.48	93.07
Current Portion of Long-Term Debt	-	2.48	2.48	-	-	-
Current Portion of Leases	-	24.14	24.59	21.82	21.59	19.34
Current Income Taxes Payable	-	10.17	9.84	18.88	16.44	21.56
Current Unearned Revenue	-	-	-	-	-	31.54
Other Current Liabilities	-	180.75	224.75	174.64	216.62	137.14
Total Current Liabilities	-	543.81	568.84	561.65	539.32	448.12
Long-Term Debt	-	400	400	-	-	-
Long-Term Leases	-	108.32	126.76	133.88	106.32	101.93
Pension & Post-Retirement Benefits	-	8.7	14.9	7.66	8.48	56.9
Long-Term Deferred Tax Liabilities	-	132.22	138.48	35.04	22.38	15.44
Other Long-Term Liabilities	-	82.62	87.75	121.79	116.24	96.2
Total Liabilities	-	1,276	1,337	860.02	792.73	718.59

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Common Stock	-	89.44	89.44	89.44	89.44	89.44
Additional Paid-In Capital	-	620.14	620.14	620.14	620.14	620.14
Retained Earnings	-	1,575	1,486	1,406	1,214	1,000
Treasury Stock	-	-150.08	-150.08	-	-	-
Comprehensive Income & Other	-	-18.11	-4.23	43.97	91.63	-50.73
Total Common Equity	2,099	2,117	2,042	2,159	2,015	1,659
Minority Interest	-	11.19	14.78	13.45	14.99	18.06
Shareholders' Equity	2,108	2,128	2,056	2,173	2,030	1,677
Total Liabilities & Equity	-	3,403	3,393	3,033	2,823	2,396

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Total Debt	580.95	534.94	553.83	155.7	127.9	121.27
Net Cash (Debt)	-557.06	-507.67	-533.54	-145.1	-120.17	-113.83
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-6.39	-5.80	-6.00	-1.62	-1.34	-1.27
Filing Date Shares Outstanding	86.3	87.54	87.54	89.44	89.44	89.44
Total Common Shares Outstanding	86.3	87.54	87.54	89.44	89.44	89.44
Working Capital	-	736.49	643.65	1,350	1,253	1,156
Book Value Per Share	23.98	24.18	23.32	24.14	22.53	18.55
Tangible Book Value	490.67	866.84	754.72	1,730	1,570	1,314
Tangible Book Value Per Share	5.61	9.90	8.62	19.35	17.55	14.69
Land	-	264.39	222.69	208.39	181.88	161.13
Machinery	-	319.39	302.78	274.66	242.04	196.58
Order Backlog	-	379.65	282.86	408.9	662.9	273.9

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error